Cargando…

Targeting Non-Oncogene Addiction for Cancer Therapy

While Next-Generation Sequencing (NGS) and technological advances have been useful in identifying genetic profiles of tumorigenesis, novel target proteins and various clinical biomarkers, cancer continues to be a major global health threat. DNA replication, DNA damage response (DDR) and repair, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Hae Ryung, Jung, Eunyoung, Cho, Soobin, Jeon, Young-Jun, Kim, Yonghwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909239/ https://www.ncbi.nlm.nih.gov/pubmed/33498235 http://dx.doi.org/10.3390/biom11020129

Ejemplares similares

Drugging the addict: non‐oncogene addiction as a target for cancer therapy
por: Nagel, Remco, et al.
Publicado: (2016)

Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer
por: Anania, Maria Chiara, et al.
Publicado: (2020)

Targeting of non-oncogene addiction
por: Igea, Ana, et al.
Publicado: (2015)

Oncogene addiction in gliomas: Implications for molecular targeted therapy
por: Yan, Wei, et al.
Publicado: (2011)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
por: De Carlo, Elisa, et al.
Publicado: (2022)

Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
por: Listì, Angela, et al.
Publicado: (2019)

Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
por: Torti, Davide, et al.
Publicado: (2011)

Immunotherapy in oncogene addicted non-small cell lung cancer
por: McLean, Luke, et al.
Publicado: (2021)

Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
por: Calabrese, Fiorella, et al.
Publicado: (2022)

A view on EGFR-targeted therapies from the oncogene-addiction perspective
por: Perez, Rolando, et al.
Publicado: (2013)

Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells
por: Amin, Amit Dipak, et al.
Publicado: (2015)

Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives
por: Ferrara, Miriam Grazia, et al.
Publicado: (2020)

Pan-cancer analysis of non-oncogene addiction to DNA repair
por: Bermúdez-Guzmán, Luis
Publicado: (2021)

Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2
por: Kim, Myung-Jin, et al.
Publicado: (2017)

RNF126, 168 and CUL1: The Potential Utilization of Multi-Functional E3 Ubiquitin Ligases in Genome Maintenance for Cancer Therapy
por: Chang, Hae Ryung
Publicado: (2023)

Oncogene-like addiction to aneuploidy in human cancers
por: Girish, Vishruth, et al.
Publicado: (2023)

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer
por: Turkaj, Ana, et al.
Publicado: (2018)

Oncogene addiction and tumor mutational burden in non‐small‐cell lung cancer: Clinical significance and limitations
por: Smolle, Elisabeth, et al.
Publicado: (2019)

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
por: Lee, Matilda, et al.
Publicado: (2018)

Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
por: Doerr, Fabian, et al.
Publicado: (2017)

An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2022)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Mutant Oncogenes. Targets for Therapy
por: Børresen, A.-L.
Publicado: (1993)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer
por: Guo, Yijia, et al.
Publicado: (2019)

Oncogene addiction: resetting the safety switch?
por: Li, Yulin, et al.
Publicado: (2014)

BIM-mediated apoptosis and oncogene addiction
por: Li, Yulin, et al.
Publicado: (2016)

Rhabdomyosarcomas are oncogene addicted to the activation of AVIL
por: Xie, Zhongqiu, et al.
Publicado: (2022)

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
por: Putcha, Preeti, et al.
Publicado: (2015)

SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy
por: Drilon, Alexander, et al.
Publicado: (2023)

Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2023)

Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
por: Sunaga, Noriaki, et al.
Publicado: (2021)

Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy
por: Qi, Xiao-Mei, et al.
Publicado: (2018)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment
por: Remon, J., et al.
Publicado: (2018)

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
por: Putcha, Preeti, et al.
Publicado: (2017)

ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology
por: Jacobi, Nico, et al.
Publicado: (2017)

Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC
por: Iacovino, Marialucia, et al.
Publicado: (2020)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Oncogenic addiction to high 26S proteasome level
por: Tsvetkov, Peter, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_50a2nh3cedd3mdun1jj1npeq95